Back to Trades
Borgeson Blake
DirectorCIK 0001856094
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Borgeson Blake, Director, has filed 7 reports across 1 company, totaling $3.2M in disclosed volume. Sales ($3.2M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Grant | $0 |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $110.4K |
| May 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $105.6K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $93.0K |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $924.0K |
| Jan 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $959.2K |
| Dec 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $961.4K |
7 filings